Articles linked to patient safety issues
Please find all related articles below.
On 3rd December 2013, different stakeholders of the healthcare system including nurses, social care workers, doctors, patients, citizens, researchers and industry met in Warsaw for the kick-off meeting of the ENS4Care project, with the ambition of developing together evidence based guidelines on eHealth services for nursing and social care.
Although most of the stakeholders met yesterday for the first time, the dynamism, creativity and commitment to work together in designing guidelines (...)
The second Conference of Partners entitled ’Scaling up for healthy growth’ presented the progress that the European Innovation Partnership on Healthy and Active Ageing (EIP on AHA) has made over the last year in the EIP’s six action areas. It highlighted ageing-related innovation, both social and technological, as a crucial area for health investment.
The conference was opened by European Commissioner for Health Policy, Tonio Borg who stressed the need for health system (...)
The European Commission has recently published a Staff Working Document (SWD) exploring the potential of Personalised Medicine, reporting on recent developments in the EU legislation, as well as looking at the factors affecting the uptake of personalised medicine in healthcare systems.
Personalised Medicine is now more close to be effective to patients, which means that treatments can be designed taking into account a specific patient group and hence able to tackle the problem with the (...)
Access to Medicines
Pharmaceuticals and Medicines
Health Rights and Patients
Brussels, 18 November – Today marks the 6th European Antibiotic Awareness Day (1), an initiative to raise awareness on antibiotic resistance (AMR), one of today’s most serious public health threats not only in Europe but worldwide. Over recent decades, growing mobility of the global population has increased the risk and incidence of cross-border diseases, and antimicrobials have been instrumental in preventing and treating such infections.
AMR results from the overuse or (...)
The transposition period for the Cross-border Healthcare Directive came to an end on 25 October, however it has been reported that many Member States are not prepared and have not set up vital information and control resources.
An article published on Euractiv on 24 October revealed that some EU countries are falling so far behind that it could take years for them to fully comply with the new EU legislation and create the required control centres and information websites. Such Member (...)
On 9 October, the European Parliament overwhelmingly voted in favour of adopting a modernised Professional Qualifications Directive (DIR36), which introduces new rules including more stringent requirements to be met by mobile health professionals in order to safeguard patient safety, and a simplified administrative procedure for swifter mutual recognition of professional qualifications between Member States.
The modernisation of DIR36 was one of twelve key actions identified by (...)
On 22 October, the European Parliament (EP) voted in plenary on one of the most discussed pieces of legislation in recent months, the proposals for Regulations on Medical Devices and In Vitro Diagnostic (IVD) Medical Devices. The newly-approved rules will bring more transparency during the entire process. Some provisions were rejected, such as the centralised pre-market authorisation system (PMA) and the provision stating that certain devices may only be supplied upon medical prescription. (...)
On 25 September the European Parliaments’ Committee for the Environment and Public Health (ENVI) approved stricter rules on medical devices in order to protect the patients.
27 September, 2013 - Stricter rules on medical devices such as a new pre-market approval system, more transparency and better traceability were voted on ENVI Committee last 25 September.
Clear rules were introduced by Members of the European Parliament (MEPs) to boost public access to clinical data, create a new (...)
The European Parliament’s ENVI Committee vote on the proposals for Regulations on Medical Devices and InVitro Medical Devices has been postponed for the second time. There are rising concerns by health stakeholders regarding the speed of the process, as ongoing delays undermine public trust in the EU’s ability to create legislation that will adequately protect patients.
On Wednesday 18 September, the ENVI committee postponed the vote on the Medical Devices Regulations for the (...)
One year after the release of its original position paper, EPHA has revised the document following member discussions about the evolving developments at EU level.
The updated EPHA Position on Medical Devices refers in particular to a number of points contained in the European Parliament reports produced by Rapporteurs Dagmar Roth-Behrendt (S&D, Germany) on medical devices and Peter Liese (S&D, Germany) on in vitro diagnostic medical devices and the subsequent debates over the most (...)